Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 1
Open Access
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Stem Cell Research
- Vol. 38, 101467
Abstract
No abstract availableKeywords
Funding Information
- Oxalosis and Hyperoxaluria Foundation
- Association Française contre les Myopathies
This publication has 48 references indexed in Scilit:
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Metabolic Correction of Congenital Erythropoietic Porphyria with iPSCs Free of Reprogramming FactorsThe American Journal of Human Genetics, 2012
- Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectorsProceedings of the National Academy of Sciences, 2011
- Phenotypic Correction of a Mouse Model for Primary Hyperoxaluria With Adeno-associated Virus Gene TransferMolecular Therapy, 2011
- Primary HyperoxaluriaInternational Journal of Nephrology, 2011
- Transplantation Outcomes in Primary HyperoxaluriaAmerican Journal of Transplantation, 2010
- Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cellsJournal of Clinical Investigation, 2010
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Gene therapy for severe combined immunodeficiency: are we there yet?Journal of Clinical Investigation, 2007
- Alanine–glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transferProceedings of the National Academy of Sciences, 2006